4-1 Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node-Negative Breast Cancer Patients

I. Bedrosian

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of '4-1 Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node-Negative Breast Cancer Patients'. Together they form a unique fingerprint.